Home › Gaucher Disease › Minnesota › Minneapolis
Gaucher Disease clinical trials in Minneapolis, MN
5 studies for Gaucher Disease are looking for participants at sites in and around Minneapolis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Oxidative Stress and Inflammatory Biomarkers in Gaucher Disease
RecruitingObservational study
- University of Minnesota, Minneapolis
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry
RecruitingObservational study
- Children's Hospitals and Clinics of Minnesota- Site Number : 840046, Minneapolis
- Children's Hospitals and Clinics of Minnesota- Site Number : 840114, Minneapolis
- M Health Fairview University of Minnesota Medical Center - West Bank- Site Number : 840076, Minneapolis
A Gaucher Disease Gene Therapy Trial With FLT201
RecruitingPhase 3
- University of Minnesota, Minneapolis
MAGNETIC RESONANCE SPECTROSCOPY BIOMARKERS IN TYPE 3 GAUCHER DISEASE (GD3)
RecruitingObservational study
- University of Minnesota, Minneapolis
Extracellular Vesicles as Potential Biomarkers and Therapeutic Target in Gaucher Disease
RecruitingObservational study
- University of Minnesota, Minneapolis
About Gaucher Disease
Gaucher disease is a rare, inherited disorder in which you do not have enough of an enzyme called glucocerebrosidase. Learn about the three types.
More about Gaucher Disease on MedlinePlus
Gaucher Disease trials in other cities
Other studies in Minneapolis
- Non-Small Cell Lung Cancer29 studies
- Breast Cancer23 studies
- Ovarian Cancer23 studies
- Prostate Cancer22 studies
- Heart Failure22 studies
- Cancer (all types)21 studies
- Endometrial Cancer20 studies
- Colorectal Cancer20 studies
- Lung Cancer20 studies
- Acute Myeloid Leukemia19 studies
- Parkinson's Disease17 studies
- Coronary Artery Disease15 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.